Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.
NCT05560555
·
clinicaltrials.gov ↗
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class
Conditions
Hereditary Transthyretin Amyloidosis (ATTRv)
Polyneuropathy
Interventions
DRUG:
Tafamidis
Sponsor
Pfizer